Synapse - Infectious Disease

Results (22)

Letermovir for prevention of recurrent cytomegalovirus in high-risk allogeneic hematopoietic cell transplantation recipients

Journal Article

Han, G.; Stern, A.; Lee, Y. J.; Li, Y.; Dahi, P. B.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Shaffer, B.; more...
Transplantation and Cellular Therapy (2025)

Fulltext@MSK | Save

Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy

Journal Article

Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
Transplantation and Cellular Therapy (2024)

Fulltext@MSK | Save

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

Journal Article

Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
Journal of Clinical Investigation (2023)

Fulltext@MSK | Save

Outcomes and management of SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation (HCT) and CAR-T therapy

Meeting Abstract

Infante, M. S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Politikos, I.; Barker, J. N.; Babady, N. E.; Ramanathan, L.; Seo, S.; more...
Blood (2022)

Fulltext@MSK | Save

Impact of letermovir primary cytomegalovirus prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation: A retrospective cohort study

Journal Article

Su, Y.; Stern, A.; Karantoni, E.; Nawar, T.; Han, G.; Zavras, P.; Dumke, H.; Cho, C.; Tamari, R.; Shaffer, B.; more...
Clinical Infectious Diseases (2022)

Fulltext@MSK | Save

Humoral response to COVID-19 vaccination given pre-cellular therapy wanes in patients after cellular therapy: An argument for full reimmunization

Meeting Abstract

Shah, G. L.; Chung, D. J.; Tamari, R.; Politikos, I.; Jakubowski, A. A.; Marcello, L.; Doddi, S.; Ramanathan, L.; Pessin, M.; Palazzo, M.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Outcomes of refractory cytomegalovirus infection in the first year after allogeneic hematopoietic cell transplantation

Journal Article

Karantoni, E.; Zavras, P. D.; Su, Y.; Fang, J.; Tamari, R.; Cho, C.; Perales, M. A.; Stern, A.; Papanicolaou, G. A.
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Human herpesvirus 6 DNAemia is associated with worse survival after ex vivo T-cell-depleted hematopoietic cell transplant

Journal Article

Lee, Y. J.; Su, Y.; Cho, C.; Tamari, R.; Perales, M. A.; Jakubowski, A. A.; Papanicolaou, G. A.
Journal of Infectious Diseases (2022)

Fulltext@MSK | Save

Timing and immune status after cellular therapies predict response to COVID-19 vaccines

Meeting Abstract

Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
Blood (2021)

Fulltext@MSK | Save

Predictors of humoral response to SARS-CoV-2 vaccination after hematopoietic cell transplantation and CAR T-cell therapy

Journal Article

Tamari, R.; Politikos, I.; Knorr, D. A.; Vardhana, S. A.; Young, J. C.; Marcello, L. T.; Doddi, S.; Devlin, S. M.; Ramanathan, L. V.; Pessin, M. S.; more...
Blood Cancer Discovery (2021)

Fulltext@MSK | Save